Vancouver, BC (February 8, 2023) ‐ WEX Pharmaceuticals Inc. (“WEX” or the “Company”), a biotechnology company developing Halneuron® (Tetrodotoxin or TTX) for pain, is pleased to announce the following executive appointments, effective immediately. Mr. Walter Korz will assume the role of Chief Executive Officer (CEO) of the Company, and Mr. Abner Yong will assume the role of Chief Financial Officer.
Menu
